drugset / Trial / NCT01684072

Safety and Immunogenicity Study of Live Attenuated Vaccine Against Varicella Without Gelatin

NCT01684072 ↗

Phase 4 Completed 1200 enrolled Beijing Center for Disease Control and Prevention
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to observe the occurrence of adverse reaction and antibody positive rate, the elevated level of antibody,Geometric mean titer (GMT) between groups of live attenuated varicella vaccine without gelatin.

Timeline

Start
2011-01
Primary completion
2011-09
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Subject vaccine with gelatin Unknown — Other
Subject vaccine without gelatin Vaccine — Other